Purpose: To compare the clinical efficacy and safety of uterine artery embolization (UAE) and robot-assisted adenomyomectomy (RAA) in symptomatic adenomyosis treatment.
Material and methods: From January 2018 to May 2021, 67 women with symptomatic adenomyosis underwent UAE (n = 48) or RAA (n = 19). Uterine volume reduction, variation in hemoglobin levels, pictorial blood loss assessment chart (PBAC), and symptom severity questionnaire were compared before and after the procedure. Procedure time, length of hospital stay, and decreased hemoglobin levels immediately after the procedures were also compared to assess complications.
Results: The two groups showed the similar outcomes in the mean uterine volume reduction rate and increased hemoglobin ratio at 3–6 months after the procedure. UAE, compared with RAA showed significantly shorter procedure time and length of hospital stay, and significantly smaller hemoglobin decreased ratio immediately after the procedure (p < 0.05). Two groups showed similar decreased ratio of the PBAC score. UAE, compared with RAA, showed significantly higher difference in symptom severity (p <0.05).
Conclusion: The UAE, with similar efficacy to the RAA, is less invasive and safer than RAA in symptomatic adenomyosis treatment.